Optimization and evaluation of nebivolol hydrochloride loaded transferosomes using Box-Behnken experimental design

P V Shelke; Punit R  Rachh; Someshwar Mankar; Saurin  Amin; Deepak Jain

doi:10.69857/joapr.v12i4.590

Authors

P V Shelke Department of Pharmaceutical Science, Bhagwant University, Ajmer, Rajasthan, India
Punit R Rachh Department of Pharmaceutical Science, Bhagwant University, Ajmer, Rajasthan, India
Someshwar Mankar Pravara Rural College of Pharmacy, Loni, Maharashtra, India
Saurin Amin Gujarat Technological University, Gujarat, India
Deepak Jain Senores Pharmaceuticals Pvt. Ltd., One42 South Tower, Ashok Vatika, Ahmedabad, Gujarat 380058 India

DOI:

https://doi.org/10.69857/joapr.v12i4.590

Keywords:

Transferosomes, Hypertension, Nebivolol hydrochloride, Box-Behnken design, Stability study

Abstract

Background: This study optimizes and evaluates transferosomes containing Nebivolol Hydrochloride to enhance the drug's bioavailability and therapeutic efficacy. Ultra-deformable vesicles called transferosomes help to increase drug administration via the skin. Methodology: Using a thin-film hydration technique, beta-blocker Nebivolol Hydrochloride, which has antihypertensive properties, was added to transferosomes. To attain the ideal vesicle size (between 200 to 300 nm), entrapment efficiency, and deformability, the formulation was adjusted by adjusting the amounts of phosphatidylcholine, Span 80, and hydration time using a Box-Behnken experimental design. Particle size analysis, zeta potential measurement, and in vitro drug release tests were performed to characterize the transferosomes. Results and discussion: The optimized formulation demonstrated notable deformability, an entrapment effectiveness of 50%, and a vesicle size of 265 nm. The Box-Behnken design made it easier to evaluate the interactions between variables systematically. In vitro drug release studies showed a drug diffusion that persisted for a whole day, suggesting that transferosomes may have long-lasting therapeutic effects. Stability studies at room temperature and accelerated conditions over six months confirmed the formulation's robustness. Conclusion: The results imply that Nebivolol Hydrochloride transferosome-based delivery may be a viable strategy for improving the drug's bioavailability and effectiveness, as nearly 100% of drugs diffuse within 24 hr, perhaps leading to a breakthrough in the management of hypertension.

Downloads

Download data is not yet available.

References

Alkilani AZ, Nasereddin J, Hamed R, Nimrawi S, Hussein G, Abo-Zour H, et al. Beneath the skin: a review of current trends and future prospects of transdermal drug delivery systems. Pharmaceutics, 14(6), 1152 (2022).

Ahad A, Al-Mohizea AM, Al-Jenoobi FI, Aqil M. Transdermal delivery of angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs) and others for management of hypertension. Drug Delivery, 23(2), 579-90 (2016).

Tanwar H, Sachdeva R. Transdermal drug delivery system: A review. International Journal of Pharmaceutical Sciences and Research, 7(6), 2274 (2016).

Sabbagh F, Kim BS. Recent advances in polymeric transdermal drug delivery systems. Journal of Controlled Release, 341, 132-46 (2022).

Hedaya MA. Routes of Drug Administration. In: Dash AK, Singh S, editors. Pharmaceutics. Academic Press, 537-554 (2024).

Hemrajani C, Negi P, Parashar A, Gupta G, Jha NK, Singh SK, et al. Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: A nanotechnological perspective. Biomedicine & Pharmacotherapy, 147, 112633 (2022).

Üstündağ-Okur N, Yurdasiper A, Gündoğdu E, Homan Gökçe E. Modification of solid lipid nanoparticles loaded with nebivolol hydrochloride for improvement of oral bioavailability in treatment of hypertension: Polyethylene glycol versus chitosan oligosaccharide lactate. Journal of Microencapsulation, 33(1), 30-42 (2016).

Shah A, Gandhi D, Srivastava S, Shah KJ, Mansukhani R. Heart failure: A class review of pharmacotherapy. Pharmacy and Therapeutics, 42(7), 464-472 (2017).

Farhoumand LS, Liu H, Tsimpaki T, Hendgen-Cotta UB, Rassaf T, Bechrakis NE, et al. Blockade of ß-adrenergic receptors by nebivolol enables tumor control potential for uveal melanoma in 3D tumor spheroids and 2D cultures. International Journal of Molecular Sciences, 24(6), 5894 (2023).

Matharoo N, Mohd H, Michniak-Kohn B. Transferosomes as a transdermal drug delivery system: Dermal kinetics and recent developments. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 16(1), e1918 (2024).

Garala KC, Patel JM, Dhingani AP, Dharamsi AT. Preparation and evaluation of agglomerated crystals by crystallo-co-agglomeration: an integrated approach of principal component analysis and Box–Behnken experimental design. International Journal of Pharmaceutics, 452(1-2), 135-56 (2013).

Fernández-García R, Lalatsa A, Statts L, Bolás-Fernández F, Ballesteros MP, Serrano DR. Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale. International Journal of Pharmaceutics, 573, 118817 (2020).

Abdallah MH, Abu Lila AS, Shawky SM, Almansour K, Alshammari F, Khafagy E-S, et al. Experimental design and optimization of nano-transfersomal gel to enhance the hypoglycemic activity of silymarin. Polymers, 14(3), 508 (2022).

Lei W, Yu C, Lin H, Zhou X. Development of tacrolimus-loaded transfersomes for deeper skin penetration enhancement and therapeutic effect improvement in vivo. Asian Journal of Pharmaceutical Sciences, 8(6), 336-345 (2013).

Raval MK, Garala KC, Patel JM, Parikh RK, Sheth NR. Functionality improvement of chlorzoxazone by crystallo-co-agglomeration using multivariate analysis approach. Particulate Science and Technology, 39(6), 689-711 (2021).

Kharwade R, Ali N, Gangane P, Pawar K, More S, Iqbal M, et al. DOE-assisted formulation, optimization, and characterization of tioconazole-loaded transferosomal hydrogel for the effective treatment of atopic dermatitis: in vitro and in vivo evaluation. Gels, 9(4), 303 (2023).

Rarokar NR, Saoji SD, Deole NV, Gaikwad M, Pandey A, Kamaraj C, et al. Preparation and formula optimization of cephalexin-loaded transferosomal gel by QbD to enhance the transdermal delivery: in vitro, ex vivo, and in vivo study. Journal of Drug Delivery Science and Technology, 89(1), 104968 (2023).

Zaky A. Comparative study of terbinafine hydrochloride transfersome, menthosome, and ethosome nanovesicle formulations via skin permeation and antifungal efficacy. Al-Azhar Journal of Pharmaceutical Sciences, 54(1), 18-36 (2016).

Tamilarasan N, Yasmin BM, Anitha P, Umme H, Cheng WH, Mohan S, et al. Box–Behnken design: optimization of proanthocyanidin-loaded transferosomes as an effective therapeutic approach for osteoarthritis. Nanomaterials, 12(17), 2954 (2022).

Saha R, Patkar S, Maniar D, Pillai MM, Tayalia P. A bilayered skin substitute developed using an eggshell membrane crosslinked gelatin–chitosan cryogel. Biomaterials Science, 9(23), 7921-33 (2021).

Garala KC, Shah PH. Influence of crosslinking agent on the release of drug from the matrix transdermal patches of HPMC/Eudragit RL 100 polymer blends. Journal of Macromolecular Science®, Part A: Pure and Applied Chemistry, 47(3), 273-81 (2010).

Yameen SH, Shahidulla S. Formulation and evaluation of lamivudine transferosomal gel. Journal of Drug Delivery and Therapeutics, 12(4-S), 163-70 (2022).

Basu B, Garala KK, Patel R, Dutta A, Ash D, Prajapati B, et al. Advanced targeted drug delivery of bioactive nanomaterials in the management of cancer. Current Medicinal Chemistry, 31(1) (2024).

Dhingani A, Patel J, Garala K, Raval M, Dharamsi A. Quality by design approach for development of W/O type microemulsion-based transdermal systems for atenolol. Journal of Dispersion Science and Technology, 35(5), 619-40 (2014).

Garala KC, Patel JM, Dhingani AP, Dharamsi AT. Quality by design (QbD) approach for developing agglomerates containing racecadotril and loperamide hydrochloride by crystallo-co-agglomeration. Powder Technology, 247, 128-46 (2013).

Bnyan R, Khan I, Ehtezazi T, Saleem I, Gordon S, O'Neill F, et al. Surfactant effects on lipid-based vesicles properties. Journal of Pharmaceutical Sciences, 107(5), 1237-46 (2018).

Guo H-Y, Sun H-Y, Deng G, Xu J, Wu F-G, Yu Z-W. Fabrication of asymmetric phosphatidylserine-containing lipid vesicles: a study on the effects of size, temperature, and lipid composition. Langmuir, 36(42), 12684-91 (2020).

Ismail A, Teiama M, Magdy B, Sakran W. Development of a novel bilosomal system for improved oral bioavailability of sertraline hydrochloride: Formulation design, in vitro characterization, and ex vivo and in vivo studies. AAPS PharmSciTech, 23(6), 188 (2022).

Opatha SAT, Titapiwatanakun V, Boonpisutiinant K, Chutoprapat R. Preparation, characterization and permeation study of topical gel loaded with transfersomes containing asiatic acid. Molecules, 27(15), 4865 (2022).

Fatima A, Quraishi N, Babu MS. Formulation and in-vitro evaluation of gabapentin-loaded transferosomal gel. Journal of Drug Delivery and Therapeutics, 13(12), 60-70 (2023).

Cheng Z, Kandekar U, Ma X, Bhabad V, Pandit A, Liu L, et al. Optimizing fluconazole-embedded transfersomal gel for enhanced antifungal activity and compatibility studies. Frontiers in Pharmacology, 15, 1353791 (2024).

Ahmed IF, Alheyf M, Yamany MS. PlanetiQ Radio Occultation: preliminary comparative analysis of neutral profiles vs. COSMIC and NWP models. Applied Sciences, 14(10), 4179 (2024).

Ma X, Li M, Xu X, Sun C. On the role of surface charge and surface tension tuned by surfactant in stabilizing bulk nanobubbles. Applied Surface Science, 608, 155232 (2023).

Pan L, Meng H, Li J, Liu Z, Zhang D, Liu Z, et al. Enhancement of astaxanthin bioaccessibility by encapsulation in liposomes: an in vitro study. Molecules, 29(8), 1687 (2024).

Buddhadev SS, K CG, S S, Rahamathulla M, Ahmed MM, Farhana SA, et al. Quality by design aided self-nano emulsifying drug delivery systems development for the oral delivery of benidipine: improvement of biopharmaceutical performance. Drug Delivery, 31(1), 2288801 (2024).

Guzik P, Więckowska B. Data distribution analysis–a preliminary approach to quantitative data in biomedical research. Journal of Medical Science, 92(2), 869 (2023).

Barekat S, Nasirpour A, Keramat J, Dinari M, Claeys M, Sedaghat Doost A, et al. Formulation, characterization, and physical stability of encapsulated walnut green husk (Juglans regia L.) extract in phosphatidylcholine liposomes. Journal of Dispersion Science and Technology, 45(11), 2180–2193 (2023).

Yasser M, El Naggar EE, Elfar N, Teaima MH, El-Nabarawi MA, Elhabal SF. Formulation, optimization and evaluation of ocular gel containing nebivolol HCl-loaded ultradeformable spanlastics nanovesicles: in vitro and in vivo studies. International Journal of Pharmaceutics: 10(7), 100-228 (2024).

Garala K, Joshi P, Shah M, Ramkishan A, Patel J. Formulation and evaluation of periodontal in situ gel. International Journal of Pharmaceutical Investigation, 3(1), 29 (2013).

Unagolla JM, Jayasuriya AC. Drug transport mechanisms and in vitro release kinetics of vancomycin encapsulated chitosan-alginate polyelectrolyte microparticles as a controlled drug delivery system. European Journal of Pharmaceutical Sciences, 114, 199-209 (2018).

Bayer IS. Controlled drug release from nanoengineered polysaccharides. Pharmaceutics, 15(5), 1364 (2023).

Kapoor DU, Garg R, Gaur M, Patel MB, Minglani VV, Prajapati BG, et al. Pediatric drug delivery challenges: enhancing compliance through age-appropriate formulations and safety measures. Journal of Drug Delivery Science and Technology, 105720 (2024).

Németh Z, Csóka I, Semnani Jazani R, Sipos B, Haspel H, Kozma G, et al. Quality by design-driven zeta potential optimisation study of liposomes with charge imparting membrane additives. Pharmaceutics, 14(9), 1798 (2022).